"As a basic scientist, I was pleasantly surprised, really kind of
stunned, to receive this award. It's important recognition of cancer
immunotherapy's early success and it's great potential to extend cancer
survival for decades, and ultimately to cure some types of cancer."
In 2001, Marnie Rose, M.D., a first-year pediatric resident at
Children's Memorial Hermann Hospital, was diagnosed with a rare form of
brain cancer. Despite a courageous fight throughout treatment at
MD Anderson, she died the following year. Since 2003, the Dr. Marnie
Rose Foundation and its annual Run for the Rose 5K have honored Marnie's
memory, raising $4.75 million for brain cancer research and drug
development at MD Anderson as well as pediatric health initiatives at
Children's Memorial Hermann. Following her own recent diagnosis of
breast cancer, Lanie Rose, Marnie's mother, reflects on MD Anderson, the
Glioblastoma Moon Shot and her daughter's legacy.
After a rigorous scientific review, MD Anderson's Moon Shots Program is
zeroing in on six additional areas of focus: b-cell lymphomas,
colorectal cancer, glioblastoma, high-risk multiple myeloma, human
papillomavirus-related cancers and pancreatic cancer.
Since 1990, MD Anderson's Holiday Giving Program has brought smiles to
countless families through seasonal cards that have generated more than
$5.78 million. The annual program has provided funding for more than 200
patient assistance, community outreach, education and prevention
programs that are truly Making Cancer History®.
John Tucker of Anderson, S.C. was 15 when he first came to MD Anderson
in 1965. At that time, the institution had been in operation for 21
years, and teenage John could barely comprehend his diagnosis.
Mel Klein has been a member of the MD Anderson Cancer Center Board of
Visitors for 25 years and is currently serving his second year as chair.
An investment banker, entrepreneur, venture capitalist, attorney and
philanthropist, he is the founder of Melvyn N. Klein Interests and a
respected community leader in Corpus Christi, Texas, with business
interests in New York, Chicago, Los Angeles and other cities in the U.S.
and internationally. From 1980 to 2005, he wrote the guest column
"Feedback" for the Corpus Christi Caller-Times, later compiled
in the book "Our Time," proceeds of which benefit MD Anderson.
In 1996, he was named to the Horatio Alger Association of Distinguished
Americans. Klein and his wife, Annette, are members of the Anderson
Assembly, an organization honoring donors who've made lifetime
commitments of $1 million or more to MD Anderson. They have two
daughters, Jacqueline and Jenna.
Cancer survivor Estela Avery is a San Antonio native, a former nurse, an
avid fundraiser and executive director of the San Antonio River
Foundation. She supports MD Anderson's orbital oncology/ophthalmic
plastic surgery program in recognition of Bita Esmaeli, M.D., professor,
Ophthalmic Plastic Surgery. Here, she reflects on her cancer experience
and the importance of giving.
Rosemary Herron is a 14-year breast cancer survivor and longtime Pink
Ribbon Volunteer at MD Anderson's Nellie B. Connally Breast Center. She
also volunteers at MD Anderson in Sugar Land. In 2012, she received the
Painter Award for outstanding contributions to the Anderson Network
support group, now known as myCancerConnection. Though her breast cancer
returned two months later, she continued volunteering throughout
treatment. Rosemary and her husband Don, recently contributed $25,000 to
support a HER2 vaccine research program, Injecting Hope. The program is
led by Elizabeth Mittendorf, M.D., associate professor, Breast Surgical Oncology.
Thoughtful investigation and steady perseverance are the approaches MD
Anderson's specialists use to unlock answers to cancer's mysteries.
They're also the tactics behind Colin Chopin's history as a 30-year
Annual Fund supporter.
Patients who receive a shorter course of whole breast radiation therapy
for early-stage disease experience less toxicity and improved quality of
life compared with those who undergo longer treatment, MD Anderson
researchers report in JAMA Oncology.
As inaugural executive director of the Moon Shots Program's cancer
prevention and control platform, Joxel Garcia, M.D., leads efforts to
reduce the cancer burden, especially in the under served population.